NextCell Pharma AB (STO:NXTCL)
1.266
-0.060 (-4.52%)
Mar 9, 2026, 5:14 PM CET
NextCell Pharma AB Market Cap
NextCell Pharma AB has a market cap or net worth of 147.71 million as of March 9, 2026. Its market cap has decreased by -36.45% in one year.
Market Cap
147.71M
Enterprise Value
121.67M
Revenue
9.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.27
Market Cap Chart
Since July 13, 2017, NextCell Pharma AB's market cap has increased from 33.03M to 147.71M, an increase of 347.25%. That is a compound annual growth rate of 18.90%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Simris Group AB (PUBL) | 157.93M |
| IRLAB Therapeutics AB | 135.90M |
| Magle Chemoswed Holding AB | 161.07M |
| Xbrane Biopharma AB | 123.41M |
| Active Biotech AB | 115.46M |
| Isofol Medical AB | 194.67M |
| Sprint Bioscience AB | 198.90M |
| Initiator Pharma | 204.67M |